Lannett Company, Inc. – NYSE:LCI
Lannett Company stock price monthly change
Lannett Company stock price quarterly change
Lannett Company stock price yearly change
Lannett Company key metrics
Market Cap | 7.38M |
Enterprise value | 586.95M |
P/E | -0.04 |
EV/Sales | 1.90 |
EV/EBITDA | -5.54 |
Price/Sales | 0.02 |
Price/Book | -0.02 |
PEG ratio | N/A |
EPS | -22.98 |
Revenue | 319.56M |
EBITDA | -136.81M |
Income | -310.74M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -62.4% |
Oper. margin | -39.56% |
Gross margin | 12.26% |
EBIT margin | -39.56% |
EBITDA margin | -42.81% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLannett Company stock price history
Lannett Company stock forecast
Lannett Company financial statements
| Dec 2021 | 86.50M | -81.08M | -93.73% |
|---|---|---|---|
| Mar 2022 | 78.35M | -34.89M | -44.54% |
| Jun 2022 | 74.18M | -93.29M | -125.75% |
| Mar 2023 | 80.50M | -101.47M | -126.04% |
| Payout ratio | 0% |
|---|
| 2018 | 4.35% |
|---|---|
| 2019 | |
| 2020 | 123.13% |
| 2021 | 774.58% |
| 2022 |
| Jun 2022 | 484435000 | 735.49M | 151.83% |
|---|---|---|---|
| Sep 2022 | 467296000 | 744.85M | 159.4% |
| Dec 2022 | 438359000 | 750.63M | 171.24% |
| Mar 2023 | 334624000 | 746.88M | 223.2% |
| Dec 2021 | -3.37M | -3.28M | -36K |
|---|---|---|---|
| Mar 2022 | -1.95M | 9.38M | 58K |
| Jun 2022 | -19.01M | 600K | 41K |
| Mar 2023 | -7.92M | -1.4M | 27K |
Lannett Company alternative data
| Aug 2023 | 564 |
|---|---|
| Sep 2023 | 564 |
| Oct 2023 | 564 |
| Nov 2023 | 564 |
| Dec 2023 | 564 |
| Jan 2024 | 564 |
| Feb 2024 | 564 |
| Mar 2024 | 564 |
| Apr 2024 | 564 |
| May 2024 | 564 |
| Jun 2024 | 564 |
| Jul 2024 | 564 |
Lannett Company other data
| Period | Buy | Sel |
|---|---|---|
| Dec 2021 | 28900 | 0 |
| Feb 2022 | 139500 | 0 |
| Mar 2022 | 20000 | 0 |
| May 2022 | 50000 | 0 |
| Sep 2022 | 31159 | 0 |
| Nov 2022 | 135000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | CHAPMAN JOHN C director | Common Stock | 20,000 | $0.51 | $10,200 | ||
Purchase | CREW TIMOTHY C officer: Chief Ex.. | Common Stock | 15,000 | $0.48 | $7,200 | ||
Purchase | LEPORE PATRICK G director | Common Stock | 100,000 | $0.49 | $49,000 | ||
Purchase | REWOLINSKI MELISSA director | Common stock | 31,159 | $0.49 | $15,268 | ||
Purchase | LEPORE PATRICK G director | Common Stock | 50,000 | $0.54 | $27,000 | ||
Purchase | FARBER JEFFREY director, 10 percent owner | Common Stock | 20,000 | $0.81 | $16,200 | ||
Purchase | ISRAEL SAMUEL H officer: Chief Le.. | Common Stock | 12,000 | $0.81 | $9,720 | ||
Purchase | CHAPMAN JOHN C director | Common Stock | 12,500 | $0.8 | $10,000 | ||
Purchase | CREW TIMOTHY C officer: Chief Ex.. | Common Stock | 50,000 | $0.93 | $46,500 | ||
Purchase | ABT JOHN officer: Chief Qu.. | Common Stock | 5,000 | $0.9 | $4,500 |
| Quarter | Transcript |
|---|---|
| Q2 2023 1 Feb 2023 | Q2 2023 Earnings Call Transcript |
| Q1 2023 2 Nov 2022 | Q1 2023 Earnings Call Transcript |
| Q4 2022 24 Aug 2022 | Q4 2022 Earnings Call Transcript |
| Q3 2022 4 May 2022 | Q3 2022 Earnings Call Transcript |
-
When is Lannett Company's next earnings date?
Unfortunately, Lannett Company's (LCI) next earnings date is currently unknown.
-
Does Lannett Company pay dividends?
No, Lannett Company does not pay dividends.
-
How much money does Lannett Company make?
Lannett Company has a market capitalization of 7.38M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 28.86% to 340.58M US dollars.
-
What is Lannett Company's stock symbol?
Lannett Company, Inc. is traded on the NYSE under the ticker symbol "LCI".
-
What is Lannett Company's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Lannett Company?
Shares of Lannett Company can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Lannett Company's key executives?
Lannett Company's management team includes the following people:
- Mr. Timothy C. Crew Chief Executive Officer & Director(age: 64, pay: $1,030,000)
- Ms. Maureen M. Cavanaugh Senior Vice President & Chief Commercial Operations Officer(age: 66, pay: $571,280)
- Mr. John Kozlowski Vice President of Fin., Chief Financial Officer & Principal Accounting Officer(age: 53, pay: $531,840)
- Mr. Samuel H. Israel Gen. Counsel & Chief Legal Officer(age: 63, pay: $521,950)
- Mr. John M. Abt Vice President and Chief Quality & Operations Officer(age: 60, pay: $444,740)
-
How many employees does Lannett Company have?
As Jul 2024, Lannett Company employs 564 workers.
-
When Lannett Company went public?
Lannett Company, Inc. is publicly traded company for more then 11 years since IPO on 13 Dec 2013.
-
What is Lannett Company's official website?
The official website for Lannett Company is lannett.com.
-
Where are Lannett Company's headquarters?
Lannett Company is headquartered at 1150 Northbrook Drive, Trevose, PA.
-
How can i contact Lannett Company?
Lannett Company's mailing address is 1150 Northbrook Drive, Trevose, PA and company can be reached via phone at 215 333 9000.
Lannett Company company profile:
Lannett Company, Inc.
lannett.comNYSE
564
Drug Manufacturers - Specialty & Generic
Healthcare
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.
Trevose, PA 19053
CIK: 0000057725
ISIN: US5160121019
CUSIP: 516012101
